The challenge of follow-up in a low-income colposcopy clinic: Characteristics associated with noncompliance in high-risk populations

Journal of Lower Genital Tract Disease

Volumn 16, Issue 4, 2012, Pages 345-351

  Chase, Dana M ^a   Osann, Kathryn ^b   Sepina, Nicole ^b   Wenzel, Lari ^b   Tewari, Krishnansu S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cervical intraepithelial neoplasia; colposcopy; compliance; health disparities

Indexed keywords

ADULT; ARTICLE; CANCER RISK; COLPOSCOPY; EMERGENCY HEALTH SERVICE; FEMALE; FOLLOW UP; GOVERNMENT; HEALTH INSURANCE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MEDICAL RECORD; PATIENT COMPLIANCE; PATIENT REFERRAL; PREGNANCY; RACE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS INFECTION; WART VIRUS;

ADULT; CALIFORNIA; ETHNIC GROUPS; FEMALE; HUMANS; MIDDLE AGED; PATIENT COMPLIANCE; POVERTY; PREGNANCY; UTERINE CERVICAL DISEASES; YOUNG ADULT;

EID: 84867580790     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e318249640f     Document Type: Article

References (35)

1. Newmann SJ, Garner EO. Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control 2005;16:63-70.
2. LeYden WA, Manos MM, Geiger AM, Weinmann S, Mouchawar J, Bischoff K, et al. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst 2005;97:675-83.
3. American Cancer SocietY. Cancer Facts & Figures. 2011. Atlanta, GA: American Cancer SocietY; 2011.
4. Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, et al. Cancer disparities bY race/ethnicitY and socioeconomic status. CA Cancer J Clin 2004;54:78-93.
5. Barnholtz-Sloan J, Patel N, Rollison D, Kortepeter K, MacKinnon J, Giuliano A. Incidence trends of invasive cervical cancer in the United States bY combined race and ethnicitY. Cancer Causes Control 2009;20:1129-38.
6. Mandelblatt J, Andrews H, Kerner J, Zauber A, Burnett W. Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital tYpe. Am J Public Health 1991;81:646-9.
7. Akers AY, Newmann SJ, Smith JS. Factors underlYing disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer 2007;31:157-81.
8. Clegg LX, Reichman ME, Miller BA, HankeY BF, Singh GK, Lin YD, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiologY, and end results: National Longitudinal MortalitY StudY. Cancer Causes Control 2009;20:417-35.
9. Behbakht K, LYnch A, Teal S, Degeest K, Massad S. Social and cultural barriers to Papanicolaou test screening in an urban population. Obstet GYnecol 2004;104:1355-61.
10. Schiffman MH, Brinton LA. The epidemiologY of cervical carcinogenesis. Cancer 1995;76(10 suppl):1888-901.
11. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, 2006 ASCCP-Sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Lower Gen Tract Dis 2007;11:201-22.
12. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 American SocietY for ColposcopY and Cervical PathologY-Sponsored Consensus Conference. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet GYnecol 2007;197:340-5.
13. Raab SS, GrzYbicki DM, Zarbo RJ, Jensen C, GeYer SJ, JanoskY JE, et al. FrequencY and outcome of cervical cancer prevention failures in the United States. Am J Clin Pathol 2007; 128:817-24.
14. Khanna N, Phillips MD. Adherence to care plan in women with abnormal Papanicolaou smears: a review of barriers and interventions. J Am Board Fam Pract 2001;14: 123-30.
15. Pretorius RG, Peterson P, Azizi F, Burchette RJ. Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less. Am J Obstet GYnecol 2006;195:1260-5.
16. Wentzensen N, Schiffman M, Dunn ST, Zuna RE, Walker J, Allen RA, et al. Grading the severitY of cervical neoplasia based on combined histopathologY, cYtopathologY, and HPV genotYpe distribution among 1,700 women referred to colposcopY in Oklahoma. Int J Cancer 2009;124: 964-9.
17. Cestero RM. Risk of high-grade cervical intraepithelial neoplasia (CIN 2/3) or cancer during follow-up of human papillomavirus (HPV) infection or CIN 1. Am J Obstet GYnecol 2006;195:1196-7.
18. Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiologY and pathophYsiologY. GYnecol Oncol 2007;107(2 suppl 1):S2-5.
19. KYrgiou M, Koliopoulos G, Martin-Hirsch P, ArbYn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or earlY invasive cervical lesions: sYstematic review and meta-analYsis. Lancet 2006;367:489-98.
20. Dodson M. UCI Medical Center Celebrates 25- Year AnniversarY. Available at: http://www.healthcare.uci.edu/ news-releases.asp?filename=25anniv.htm. AccessedNovember 20, 2001.
21. Santa Ana, California (CA) povertY rate dataVinformation about poor and low income residents. Available at: http:// www.citY-data.com/povertY/povertY- Santa-Ana-California.html.
22. Mart?́n-López R, Hernández-Barrera V, Lopez De Andres A, Garrido PC, Gil De Miguel A, Garc?́a RJ. Breast and cervical cancer screening in Spain and predictors of adherence. Eur J Cancer Prev 2010;19:227-38.
23. Campbell FN, Lara-Torre E. Follow-up compliance of adolescents with cervical dYsplasia in an inner-citY population. J Pediatr Adolesc GYnecol 2009;22:151-5.
24. Kwak MS, Choi KS, Spring BJ, Park S, Park EC. Predicting the stages of adoption of cervical cancer screening among Korean women. Prev Med 2009;49:48-53.
25. Chase DM, KalouYan M, DiSaia PJ. ColposcopY to evaluate abnormal cervical cYtologY in 2008. Am J Obstet GYnecol 2009;200:472-80.
26. Kalantari M, Chase DM, Tewari KS, Bernard HU. Recombination of human papillomavirus-16 and host DNA in exfoliated cervical cells: a pilot studY of L1 gene methYlation and chromosomal integration as biomarkers of carcinogenic progression. J Med Virol 2010;82:311-20.
27. Kahn JA, Lan D, Kahn RS. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet GYnecol 2007;110:87-95.
28. Erratum in: Obstet G-necol. 2007 Sep;110(3):713.
29. El-ShalakanY A, Hassan SS, Ammar E, Ibrahim MA, Salam MA, Farid M. Direct visual inspection of the cervix for the detection of premalignant lesions. J Lower Gen Tract Dis 2004;8:16-20.
30. Pérez-Stable EJ, Sabogal F, Otero-Sabogal R, Hiatt RA, McPhee SJ. Misconceptions about cancer among Latinos and Anglos. JAMA 1992;268:3219-23.
31. Abdullahi A, Copping J, Kessel A, Luck M, Bonell C. Cervical screening: perceptions and barriers to uptake among Somali women in Camden. Public Health 2009;123:680-5.
32. Matin M, LeBaron S. Attitudes toward cervical cancer screening among Muslim women: A pilot study. Women Health 2004;39:63-77
33. Mamon JA, Shediac MC, CrosbY CB, Sanders B, Matanoski GM, Celentano DD. Inner-citY women at risk for cervical cancer: behavioral and utilization factors related to inadequate screening. Prev Med 1990;19:363-76.
34. Giles M, Garland S. A studY of women's knowledge regarding human papillomavirus infection, cervical cancer and human papillomavirus vaccines. Aust N Z J Obstet GYnaecol 2006;46:311-5.
35. Massad LS, MeYer P, Hobbs J. Knowledge of cervical cancer screening among women attending urban colposcopY clinics. Cancer Detect Prev 1997;21:103-9.